share_log

Ardelyx | 4: Statement of changes in beneficial ownership of securities-Officer Williams Laura A

Ardelyx | 4: Statement of changes in beneficial ownership of securities-Officer Williams Laura A

Ardelyx | 4:持股變動聲明-高管 Williams Laura A
美股SEC公告 ·  08/22 18:45

Moomoo AI 已提取核心訊息

Ardelyx's Chief Medical Officer, Laura A. Williams, completed a sale of 7,412 shares of common stock on 08/20/2024. The transaction was executed at a price of $5.8603 per share, resulting in a total sale value of $43,436.54. Following the sale, Williams holds a total of 314,740 Ardelyx shares directly. The sale took place in an open market or private sale, as per the transaction code description.
Ardelyx's Chief Medical Officer, Laura A. Williams, completed a sale of 7,412 shares of common stock on 08/20/2024. The transaction was executed at a price of $5.8603 per share, resulting in a total sale value of $43,436.54. Following the sale, Williams holds a total of 314,740 Ardelyx shares directly. The sale took place in an open market or private sale, as per the transaction code description.
ardelyx的首席醫療官Laura A. Williams於2024年08月20日完成了對7412股普通股的出售。該交易價格爲每股5.8603美元,總銷售價值爲43436.54美元。銷售完成後,Williams直接持有314,740股Ardelyx股票。根據交易代碼描述,該出售是在公開市場或私人出售中進行的。
ardelyx的首席醫療官Laura A. Williams於2024年08月20日完成了對7412股普通股的出售。該交易價格爲每股5.8603美元,總銷售價值爲43436.54美元。銷售完成後,Williams直接持有314,740股Ardelyx股票。根據交易代碼描述,該出售是在公開市場或私人出售中進行的。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息